Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy.

Camargo LM, França CN, Izar MC, Bianco HT, Lins LS, Barbosa SP, Pinheiro LF, Fonseca FA.

Braz J Med Biol Res. 2014 May;47(5):432-7. Epub 2014 May 2.

2.

Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk patients.

Lins LC, França CN, Fonseca FA, Barbosa SP, Matos LN, Aguirre AC, Bianco HT, do Amaral JB, Izar MC.

Cell Biochem Biophys. 2014 Sep;70(1):687-96. doi: 10.1007/s12013-014-9973-9.

PMID:
24777811
3.

Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin.

Hussein O, Minasian L, Itzkovich Y, Shestatski K, Solomon L, Zidan J.

Br J Clin Pharmacol. 2008 May;65(5):637-45. doi: 10.1111/j.1365-2125.2007.03080.x. Epub 2008 Jan 30.

4.

Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells.

Pesaro AE, Serrano CV Jr, Katz M, Marti L, Fernandes JL, Parra PR, Campos AH.

J Cardiovasc Pharmacol Ther. 2013 Sep;18(5):447-52. doi: 10.1177/1074248413489771. Epub 2013 Jun 5.

PMID:
23739650
5.

The effects of ezetimibe/simvastatin versus simvastatin monotherapy on platelet and inflammatory biomarkers in patients with metabolic syndrome.

Miller M, DiNicolantonio JJ, Can M, Grice R, Damoulakis A, Serebruany VL.

Cardiology. 2013;125(2):74-7. doi: 10.1159/000347134. Epub 2013 May 7.

PMID:
23652826
6.

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans.

Landmesser U, Bahlmann F, Mueller M, Spiekermann S, Kirchhoff N, Schulz S, Manes C, Fischer D, de Groot K, Fliser D, Fauler G, März W, Drexler H.

Circulation. 2005 May 10;111(18):2356-63. Epub 2005 May 2.

7.

Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary artery disease.

França CN, Pinheiro LF, Izar MC, Brunialti MK, Salomão R, Bianco HT, Kasmas SH, Barbosa SP, de Nucci G, Fonseca FA.

Circ J. 2012;76(3):729-36. Epub 2011 Dec 28.

8.

The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.

Olijhoek JK, Hajer GR, van der Graaf Y, Dallinga-Thie GM, Visseren FL.

J Cardiovasc Pharmacol. 2008 Aug;52(2):145-50. doi: 10.1097/FJC.0b013e31817ffe76.

PMID:
18670365
9.
10.

No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.

Malmström RE, Settergren M, Böhm F, Pernow J, Hjemdahl P.

Thromb Haemost. 2009 Jan;101(1):157-64.

PMID:
19132203
11.

Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.

Bauriedel G, Skowasch D, Schneider M, Andrié R, Jabs A, Lüderitz B.

Am Heart J. 2003 Feb;145(2):343-8.

PMID:
12595854
13.

The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers.

Efrati S, Averbukh M, Dishy V, Faygenzo M, Friedensohn L, Golik A.

Eur J Clin Pharmacol. 2007 Feb;63(2):113-21. Epub 2007 Jan 3.

PMID:
17200833
14.

Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial.

Berthold HK, Naini A, Di Mauro S, Hallikainen M, Gylling H, Krone W, Gouni-Berthold I.

Drug Saf. 2006;29(8):703-12.

PMID:
16872244
15.

Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.

Trenk D, Hochholzer W, Frundi D, Stratz C, Valina CM, Bestehorn HP, Büttner HJ, Neumann FJ.

Thromb Haemost. 2008 Jan;99(1):174-81. doi: 10.1160/TH07-08-0503.

PMID:
18217151
16.

Effects of ezetimibe/simvastatin 10/20 mg vs. atorvastatin 20 mg on apolipoprotein B/apolipoprotein A1 in Korean patients with type 2 diabetes mellitus: results of a randomized controlled trial.

Lee JH, Kang HJ, Kim HS, Sohn DW, Oh BH, Park YB.

Am J Cardiovasc Drugs. 2013 Oct;13(5):343-51. doi: 10.1007/s40256-013-0031-6.

PMID:
23728830
17.

Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin.

Pesaro AE, Serrano CV Jr, Fernandes JL, Cavalcanti AB, Campos AH, Martins HS, Maranhão RC, de Lemos JA, Souza HP, Nicolau JC.

Int J Cardiol. 2012 Jul 26;158(3):400-4. doi: 10.1016/j.ijcard.2011.01.062. Epub 2011 Feb 21.

18.

Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis.

Mäki-Petäjä KM, Booth AD, Hall FC, Wallace SM, Brown J, McEniery CM, Wilkinson IB.

J Am Coll Cardiol. 2007 Aug 28;50(9):852-8. Epub 2007 Aug 13.

20.

Supplemental Content

Support Center